Namocell Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Namocell's estimated annual revenue is currently $3.6M per year.(i)
  • Namocell's estimated revenue per employee is $155,000

Employee Data

  • Namocell has 23 Employees.(i)
  • Namocell grew their employee count by -18% last year.

Namocell's People

NameTitleEmail/Phone
1
Co-FounderReveal Email/Phone
2
Director Manufacturing EngineeringReveal Email/Phone
3
Midwest Regional Manager at NamocellReveal Email/Phone
4
Regional ManagerReveal Email/Phone
5
Account Manager, New EnglandReveal Email/Phone
6
Field Application ScientistReveal Email/Phone
7
Northwest Sales ManagerReveal Email/Phone
8
Field Application SpecialistReveal Email/Phone
9
Field Application ScientistReveal Email/Phone
10
Field Application ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Namocell?

Namocell is a leading provider of single cell sorting and dispensing platforms for life science research and drug development. Our single cell dispensers provide the fastest way to a single cell with the ability to dispense single cells into a 96 well plate in under a minute or a 384 well plate in 6 minutes. Our patented microfluidics based instruments are also gentle to the cell with low pressure helping to ensure that your cells remain viable through the sorting and dispensing process. Effortless, compact, and cost-effective our line of cell dispensers are designed to empower a variety of single cell applications, including cell line development, CRISPR, monoclonal antibody development, single cell genomics, and rare cell isolation. All of our instruments are designed and built in Mountain View, California!

keywords:N/A

N/A

Total Funding

23

Number of Employees

$3.6M

Revenue (est)

-18%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Namocell News

2022-04-20 - Worldwide Flow Cytometry Industry to 2025 - Featuring bioMerieux ...

7.22 Namocell. 7.23 Nanion. 7.24 NanoCellect Biotechnology. 7.25 Omiq. 7.26 On-Chip Biotechnologies. 7.27 Partek. 7.28 Sartorius.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.6M23-28%$72.5M
#2
$6M240%N/A
#3
N/A2420%$77M
#4
$2.4M2426%N/A
#5
$2.4M24N/AN/A